The full chemical name is N-[2-(5-methoxy-1H-indol-3-yl)ethyl]-N-propylpropan-1-amine. It is classified as a
tryptaminederivative.
Effects
Little is known about the subjective effects of 5-MeO-DPT, but the nature of the compound is probably comparable to
5-MeO-DiPT,
5-MeO-DMT, or
DPT, which are also
psychedelic tryptamines/indoles. However, the duration of the above-mentioned drugs vary considerably.
Dosage
5-MeO-DPT is
orally active, with 3-10
mg representing a fully effective dosage for most users. Effects begin within three hours, and usually last 4 hours.
Legality
In the United States 5-MeO-DPT is considered a schedule 1 controlled substance as a positional isomer of
5-Methoxy-N,N-diisopropyltryptamine (5-MeO-DiPT)[5]
^Glennon RA, Young R, Rosecrans JA, Kallman MJ (1980). "Hallucinogenic agents as discriminative stimuli: a correlation with serotonin receptor affinities". Psychopharmacology. 68 (2): 155–8.
doi:
10.1007/BF00432133.
PMID6776558.
S2CID1674481.
^Nakamoto A, Namera A, Nishida M, Yashiki M, Kuramoto T, Kimura K (June 2007). "Identification and quantitative determination of 5-methoxy-N, N-di-n-propyltryptamine in urine by isotope dilution gas chromatography-mass spectrometry". Forensic Toxicology. 25 (1): 1–7.
doi:
10.1007/s11419-006-0018-y.
S2CID9906203.
^Nakazono Y, Tsujikawa K, Kuwayama K, Kanamori T, Iwata YT, Miyamoto K, Kasuya F, Inoue H (January 2014). "Simultaneous determination of tryptamine analogues in designer drugs using gas chromatography–mass spectrometry and liquid chromatography–tandem mass spectrometry". Forensic Toxicology. 32 (1): 154–61.
doi:
10.1007/s11419-013-0208-3.
S2CID25134125.
The full chemical name is N-[2-(5-methoxy-1H-indol-3-yl)ethyl]-N-propylpropan-1-amine. It is classified as a
tryptaminederivative.
Effects
Little is known about the subjective effects of 5-MeO-DPT, but the nature of the compound is probably comparable to
5-MeO-DiPT,
5-MeO-DMT, or
DPT, which are also
psychedelic tryptamines/indoles. However, the duration of the above-mentioned drugs vary considerably.
Dosage
5-MeO-DPT is
orally active, with 3-10
mg representing a fully effective dosage for most users. Effects begin within three hours, and usually last 4 hours.
Legality
In the United States 5-MeO-DPT is considered a schedule 1 controlled substance as a positional isomer of
5-Methoxy-N,N-diisopropyltryptamine (5-MeO-DiPT)[5]
^Glennon RA, Young R, Rosecrans JA, Kallman MJ (1980). "Hallucinogenic agents as discriminative stimuli: a correlation with serotonin receptor affinities". Psychopharmacology. 68 (2): 155–8.
doi:
10.1007/BF00432133.
PMID6776558.
S2CID1674481.
^Nakamoto A, Namera A, Nishida M, Yashiki M, Kuramoto T, Kimura K (June 2007). "Identification and quantitative determination of 5-methoxy-N, N-di-n-propyltryptamine in urine by isotope dilution gas chromatography-mass spectrometry". Forensic Toxicology. 25 (1): 1–7.
doi:
10.1007/s11419-006-0018-y.
S2CID9906203.
^Nakazono Y, Tsujikawa K, Kuwayama K, Kanamori T, Iwata YT, Miyamoto K, Kasuya F, Inoue H (January 2014). "Simultaneous determination of tryptamine analogues in designer drugs using gas chromatography–mass spectrometry and liquid chromatography–tandem mass spectrometry". Forensic Toxicology. 32 (1): 154–61.
doi:
10.1007/s11419-013-0208-3.
S2CID25134125.